Systemic sclerosis associated interstitial lung disease: a conceptual framework for subclinical, clinical and progressive disease

By sjmartinez • May 3, 2023

Roofeh D, Brown KK, Kazerooni EA, Tashkin D, Assassi S, Martinez F, Wells AU, Raghu G, Denton CP, Chung L, Hoffmann-Vold AM, Distler O, Johannson KA, Allanore Y, Matteson EL, Kawano-Dourado L, Pauling JD, Seibold JR, Volkmann ER, Walsh SLF, Oddis CV, White ES, Barratt SL, Bernstein EJ, Domsic RT, Dellaripa PF, Conway R, Rosas I, Bhatt N, Hsu V, Ingegnoli F, Kahaleh B, Garcha P, Gupta N, Khanna S, Korsten P, Lin C, Mathai SC, Strand V, Doyle TJ, Steen V, Zoz DF, Ovalles-Bonilla J, Rodriguez-Pinto I, Shenoy PD, Lewandoski A, Belloli E, Lescoat A, Nagaraja V, Ye W, Huang S, Maher T, Khanna D. Systemic sclerosis associated interstitial lung disease: a conceptual framework for subclinical, clinical and progressive disease. Rheumatology (Oxford). 2023 May 2;62(5):1877-1886. doi: 10.1093/rheumatology/keac557. PMID: 36173318; PMCID: PMC10152284.

Tags: connective tissue disease interstitial lung disease, Publications, Pulmonary, Critical Care & Sleep Medicine, systemic sclerosis associated interstitial lung disease subsets, systemic sclerosis interstitial lung disease

Response to Baroukhian et al., “Pemphigus following herpes simplex infection: A global comprehensive cohort study”

Curman P, Ngo BT, Hernandez G, Kridin K, Ludwig RJ, Kasperkiewicz M. Response to Baroukhian et al., "Pemphigus following herpes simplex infection: A global comprehensive[...]

PPARγ-dependent remodeling of translational machinery in adipose progenitors is impaired in obesity

De Siqueira MK, Li G, Zhao Y, Wang S, Ahn IS, Tamboline M, Hildreth AD, Larios J, Schcolnik-Cabrera A, Nouhi Z, Zhang Z, Tol MJ,[...]

Cabotegravir Maintains Protective Efficacy in the Setting of Bacterial STIs: A Secondary Analysis of HPTN 083

Clement ME, Hanscom B, Haines D, Bazan JA, Chotirosniramit N, Kofron R, Mannheimer S, Mayer KH, Torres Silva MS, Soto-Torres L, Rinehart AR, Rooney JF,[...]